CA Patent

CA2790708A1 — Oral b12 therapy

Assigned to Emisphere Technologies Inc · Expires 2011-09-01 · 15y expired

What this patent protects

Methods of normalizing vitamin B12 levels in patients with low vitamin B12 and methods of normalizing intersubject variability in the treatment of such patients are described. Methods of reducing MMA and/or homocysteine levels, and pharmaceutical compositions useful to effect suc…

USPTO Abstract

Methods of normalizing vitamin B12 levels in patients with low vitamin B12 and methods of normalizing intersubject variability in the treatment of such patients are described. Methods of reducing MMA and/or homocysteine levels, and pharmaceutical compositions useful to effect such changes are also described.

Drugs covered by this patent

Patent Metadata

Patent number
CA2790708A1
Jurisdiction
CA
Classification
—
Expires
2011-09-01
Drug substance claim
No
Drug product claim
No
Assignee
Emisphere Technologies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.